DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
DNA-based nanocarriers to sequester altered microRNAs in cardiac dysfunction
MicroRNAs (miRs) play a critical role in modulating gene expression across biological processes, including cardiac aging and disease. As such, miRs have demonstrated therapeutic potential in several cardiac conditions. Efficient delivery of miR therapies to cardiac tissue is crucial for effective gene therapy and DNA-based nanocarriers (DNCs), based on Watson-Crick-Franklin highly specific base-pair recognition, have emerged as a promising, biocompatible alternative to viral-based methods. Here, DNCs designed to modulate miR levels as a potential treatment for cardiac dysfunction are presented. Specifically, the DNCs target miR-24-2, which inhibits SERCA2 gene. In humans, the reduction of SERCA2 activity is a hallmark of heart failure and is altered in cardiac aging. The assembled DNCs bearing anti-miR-24-2-5p sequences effectively restore intracellular levels of SERCA2 in a HEK293 cell model. The DNCs proper assembly is thoroughly verified, while their stability and miR-capture ability are demonstrated in vitro. The DNCs exhibit successful internalization into HEK293 and modest uptake into human cardiomyocytes. SERCA2 restoration by DNCs is significantly influenced by the miR-capture sequence layout, underscoring the importance of precise design for optimal biological outcomes. This study highlights the potential of DNCs in cardiac therapies, a previously unexplored avenue for addressing cardiac dysfunction., Authors acknowledge the following funding: grant LMP128_21 by Gobierno de Aragón, grant PID2020-113003GB-I00 funded by MICIU/AEI/10.13039/501100011033, PID2022-139859OB-I00 funded by MICIU/AEI/10.13039/501100011033 and ERDF, UE and Research Group grants (E47_23R and T39_23R) by Gobierno de Aragón. This study was also supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1). Authors also acknowledge DNABEATS project, Joint Transnational Call 2022 of M-ERA.NET 3, (Horizon 2020 grant agreement No 958174) and supported by grants PCI2023-143390 and PCI2023-143438 funded by MICIU/AEI/10.13039/501100011033 and cofounded by EU. N.H.-B. and M.S.-B. were funded by Gobierno de Aragón fellowships CPB_09_20 and CPB_14_22, respectively. The authors would like to acknowledge the Servicio General de Apoyo a la Investigación-SAI (Universidad de Zaragoza) and Servicios Científico-Técnicos (microscopía, UNATI, y citometría) of CIBA (IISA-IACS-Universidad de Zaragoza) for their support., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-113003GB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-139859OB-I00
,
EC / H2020 958174
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PCI2023-143390
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PCI2023-143438